Beta human papillomavirus E6 expression inhibits stabilization of p53 and increases tolerance of genomic instability

Journal of Virology

Volumn 88, Issue 11, 2014, Pages 6112-6127

  Wallace, Nicholas A ^a   Robinson, Kristin ^a   Galloway, Denise A ^a  

^a Fred Hutchinson Cancer Research Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA HUMAN PAPILLOMAVIRUS E6 PROTEIN; E1A ASSOCIATED P300 PROTEIN; PROTEIN P53; UNCLASSIFIED DRUG; VIRUS PROTEIN;

ALPHAPAPILLOMAVIRUS; ARTICLE; CELL AGING; CELL GROWTH; CELL PROLIFERATION; CENTROSOME; CONTROLLED STUDY; CYTOKINESIS; DNA DAMAGE; GENOMIC INSTABILITY; GROWTH RATE; HUMAN; HUMAN CELL; HUMAN PAPILLOMAVIRUS TYPE 38; HUMAN PAPILLOMAVIRUS TYPE 5; HUMAN PAPILLOMAVIRUS TYPE 8; MITOSIS; NEWBORN; NON MELANOMA SKIN CANCER; PAPILLOMAVIRUS INFECTION; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DEGRADATION; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN STABILITY; VIRUS CARCINOGENESIS; WART VIRUS;

ANALYSIS OF VARIANCE; BETA-GALACTOSIDASE; BETAPAPILLOMAVIRUS; FLOW CYTOMETRY; GENOMIC INSTABILITY; HUMANS; MICROSCOPY, FLUORESCENCE; ONCOGENE PROTEINS, VIRAL; PROTEIN STABILITY; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TUMOR SUPPRESSOR PROTEIN P53;

EID: 84899852107     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.03808-13     Document Type: Article

References (41)

1. Bernard HU, Burk RD, Chen Z, van Doorslaer K, Hausen H, de Villiers EM. 2010. Classification of papillomaviruses (PVs) based on 189 PV types and proposal of taxonomic amendments. Virology 401:70-79. http://dx. doi. org/10. 1016/j. virol. 2010. 02. 002.
2. zur Hausen H. 1999. Papillomaviruses in human cancers. Proc. Assoc. Am. Physicians 111:581-587. http://dx. doi. org/10. 1046/j. 1525-1381. 1999. 99723. x.
3. Cogliano V, Baan R, Straif K, Grosse Y, Secretan B, El Ghissassi F. 2005. Carcinogenicity of human papillomaviruses. Lancet Oncol. 6:204. http://dx. doi. org/10. 1016/S1470-2045(05)70086-3.
4. Lorincz AT, Reid R, Jenson AB, Greenberg MD, Lancaster W, Kurman RJ. 1992. Human papillomavirus infection of the cervix: relative risk associations of 15 common anogenital types. Obstet. Gynecol. 79:328-337. http://dx. doi. org/10. 1097/00006250-199203000-00002.
5. Orth G, Jablonska S, Jarzabek-Chorzelska M, Obalek S, Rzesa G, Favre M, Croissant O. 1979. Characteristics of the lesions and risk of malignant conversion associated with the type of human papillomavirus involved in epidermodysplasia verruciformis. Cancer Res. 39:1074-1082.
6. Bouwes Bavinck JN, Feltkamp M, Struijk L, ter Schegget J. 2001. Human papillomavirus infection and skin cancer risk in organ transplant recipients. J. Investig. Dermatol. Symp. Proc. 6:207-211. http://dx. doi. org/10. 1046/j. 0022-202x. 2001. 00048. x.
7. Lutzner MA, Blanchet-Bardon C, Orth G. 1984. Clinical observations, virologic studies, and treatment trials in patients with epidermodysplasia verruciformis, a disease induced by specific human papillomaviruses. J. Investig. Dermatol. 83: 18s-25s. http://dx. doi. org/10. 1111/1523-1747. ep12281128.
8. Pfister H. 1992. Human papillomaviruses and skin cancer. Semin. Cancer Biol. 3:263-271.
9. Akgül B, Cooke JC, Storey A. 2006. HPV-associated skin disease. J. Pathol. 208:165-175. http://dx. doi. org/10. 1002/path. 1893.
10. Wallace NA, Robinson K, Howie HL, Galloway DA. 2012. HPV 5 and 8 E6 abrogate ATR activity resulting in increased persistence of UVB induced DNA damage. PLoS Pathog. 8:e1002807. http://dx. doi. org/10. 1371/journal. ppat. 1002807.
11. Howie HL, Koop JI, Weese J, Robinson K, Wipf G, Kim L, Galloway DA. 2011. Beta-HPV 5 and 8 E6 promote p300 degradation by blocking AKT/p300 association. PLoS Pathog. 7:e1002211. http://dx. doi. org/10. 1371/journal. ppat. 1002211.
12. Gu W, Roeder RG. 1997. Activation of p53 sequence-specific DNA binding by acetylation of the p53 C-terminal domain. Cell 90:595-606. http://dx. doi. org/10. 1016/S0092-8674(00)80521-8.
13. Wallace NA, Gasior SL, Faber ZJ, Howie HL, Deininger PL, Galloway DA. 2013. HPV 5 and 8 E6 expression reduces ATM protein levels and attenuates LINE-1 retrotransposition. Virology 443:69-79. http://dx. doi. org/10. 1016/j. virol. 2013. 04. 022.
14. Shinmura K, Bennett RA, Tarapore P, Fukasawa K. 2007. Direct evidence for the role of centrosomally localized p53 in the regulation of centrosome duplication. Oncogene 26:2939-2944. http://dx. doi. org/10. 1038/sj. onc. 1210085.
15. Tarapore P, Fukasawa K. 2002. Loss of p53 and centrosome hyperamplification. Oncogene 21:6234-6240. http://dx. doi. org/10. 1038/sj. onc. 1205707.
16. Tarapore P, Horn HF, Tokuyama Y, Fukasawa K. 2001. Direct regulation of the centrosome duplication cycle by the p53-p21Waf1/Cip1 pathway. Oncogene 20:3173-3184. http://dx. doi. org/10. 1038/sj. onc. 1204424.
17. Stukenberg PT. 2004. Triggering p53 after cytokinesis failure. J. Cell Biol. 165:607-608. http://dx. doi. org/10. 1083/jcb. 200405089.
18. Shi Q, King RW. 2005. Chromosome nondisjunction yields tetraploid rather than aneuploid cells in human cell lines. Nature 437:1038-1042. http://dx. doi. org/10. 1038/nature03958.
19. Shen Y, White E. 2001. p53-dependent apoptosis pathways. Adv. Cancer Res. 82:55-84. http://dx. doi. org/10. 1016/S0065-230X(01)82002-9.
20. Agarwal ML, Agarwal A, Taylor WR, Stark GR. 1995. p53 controls both theG2/M and theG1 cell cycle checkpoints and mediates reversible growth arrest in human fibroblasts. Proc. Natl. Acad. Sci. USA. 92:8493-8497. http://dx. doi. org/10. 1073/pnas. 92. 18. 8493.
21. Duensing S, Duensing A, Crum CP, Munger K. 2001. Human papillomavirus type 16 E7 oncoprotein-induced abnormal centrosome synthesis is an early event in the evolving malignant phenotype. Cancer Res. 61: 2356-2360. http://cancerres. aacrjournals. org/content/61/6/2356. long.
22. Greider CW. 1990. Telomeres, telomerase and senescence. Bioessays 12: 363-369. http://dx. doi. org/10. 1002/bies. 950120803.
23. Moorad JA, Promislow DE. 2008. A theory of age-dependent mutation and senescence. Genetics 179:2061-2073. http://dx. doi. org/10. 1534/genetics. 108. 088526.
24. Hayflick L, Moorhead PS. 1961. The serial cultivation of human diploid cell strains. Exp. Cell Res. 25:585-621. http://dx. doi. org/10. 1016/0014-4827(61)90192-6.
25. Malanchi I, Accardi R, Diehl F, Smet A, Androphy E, Hoheisel J, Tommasino M. 2004. Human papillomavirus type 16 E6 promotes retinoblastoma protein phosphorylation and cell cycle progression. J. Virol. 78:13769-13778. http://dx. doi. org/10. 1128/JVI. 78. 24. 13769-13778. 2004.
26. Klingelhutz AJ, Foster SA, McDougall JK. 1996. Telomerase activation by the E6 gene product of human papillomavirus type 16. Nature 380:79-82. http://dx. doi. org/10. 1038/380079a0.
27. Underbrink MP, Howie HL, Bedard KM, Koop JI, Galloway DA. 2008. E6 proteins from multiple human betapapillomavirus types degrade Bak and protect keratinocytes from apoptosis after UVB irradiation. J. Virol. 82:10408-10417. http://dx. doi. org/10. 1128/JVI. 00902-08.
28. Bedard KM, Underbrink MP, Howie HL, Galloway DA. 2008. The E6 oncoproteins from human betapapillomaviruses differentially activate telomerase through an E6AP-dependent mechanism and prolong the lifespan of primary keratinocytes. J. Virol. 82:3894-3902. http://dx. doi. org/10. 1128/JVI. 01818-07.
29. Huang WC, Chen CC. 2005. Akt phosphorylation of p300 at Ser-1834 is essential for its histone acetyltransferase and transcriptional activity. Mol. Cell. Biol. 25: 6592-6602. http://dx. doi. org/10. 1128/MCB. 25. 15. 6592-6602. 2005.
30. Harley CB, Vaziri H, Counter CM, Allsopp RC. 1992. The telomere hypothesis of cellular aging. Exp. Gerontol. 27:375-382. http://dx. doi. org/10. 1016/0531-5565(92)90068-B.
31. Klingelhutz AJ, Barber SA, Smith PP, Dyer K, McDougall JK. 1994. Restoration of telomeres in human papillomavirus-immortalized human anogenital epithelial cells. Mol. Cell. Biol. 14:961-969.
32. Dimri GP, Lee X, Basile G, Acosta M, Scott G, Roskelley C, Medrano EE, Linskens M, Rubelj I, Pereira-Smith O, Peacocke M, Campisi J. 1995. A biomarker that identifies senescent human cells in culture and in aging skin in vivo. Proc. Natl. Acad. Sci. USA. 92:9363-9367. http://dx. doi. org/10. 1073/pnas. 92. 20. 9363.
33. Wiese C, Zheng Y. 2006. Microtubule nucleation: gamma-tubulin and beyond. J. Cell Sci. 119:4143-4153. http://dx. doi. org/10. 1242/jcs. 03226.
34. Duensing S, Munger K. 2002. Human papillomaviruses and centrosome duplication errors: modeling the origins of genomic instability. Oncogene 21:6241-6248. http://dx. doi. org/10. 1038/sj. onc. 1205709.
35. Scholzen T, Gerdes J. 2000. The Ki-67 protein: from the known and the unknown. J. Cell. Physiol. 182:311-322. http://dx. doi. org/10. 1002/(SICI)1097-4652(200003)182:3<311::AID-JCP1>3. 0. CO;2-9.
36. Gergely F, Basto R. 2008. Multiple centrosomes: together they stand, divided they fall. Genes Dev. 22:2291-2296. http://dx. doi. org/10. 1101/gad. 1715208.
37. Quintyne NJ, Reing JE, Hoffelder DR, Gollin SM, Saunders WS. 2005. Spindle multipolarity is prevented by centrosomal clustering. Science 307: 127-129. http://dx. doi. org/10. 1126/science. 1104905.
38. Jackson S, Harwood C, Thomas M, Banks L, Storey A. 2000. Role of Bak in UV-induced apoptosis in skin cancer and abrogation by HPV E6 proteins. Genes Dev. 14:3065-3073. http://dx. doi. org/10. 1101/gad. 182100.
39. Ha GH, Kim HS, Lee CG, Park HY, Kim EJ, Shin HJ, Lee JC, Lee KW, Lee CW. 2009. Mitotic catastrophe is the predominant response to histone acetyltransferase depletion. Cell Death Differ. 16:483-497. http://dx. doi. org/10. 1038/cdd. 2008. 182.
40. Liu L, Scolnick DM, Trievel RC, Zhang HB, Marmorstein R, Halazonetis TD, Berger SL. 1999. p53 sites acetylated in vitro by PCAF and p300 are acetylated in vivo in response to DNA damage. Mol. Cell. Biol. 19:1202-1209.
41. Müller-Schiffmann A, Beckmann J, Steger G. 2006. The E6 protein of the cutaneous human papillomavirus type 8 can stimulate the viral early and late promoters by distinct mechanisms. J. Virol. 80:8718-8728. http://dx. doi. org/10. 1128/JVI. 00250-06.